Clinical Trials
35 trialsNCT06427005 2025-01-22
Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC
West China Hospital
Phase 2 Unknown
NCT05817201 2023-04-18
Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy
Taizhou Hospital
Phase 2/3 Unknown
NCT05774964 2023-03-20
Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases
Liaoning Cancer Hospital & Institute
Phase 2 Unknown
NCT05325528 2023-02-01
Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases
Zhejiang University
Phase 2/3 Unknown
NCT05594381 2022-10-26
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT05529355 2022-09-07
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Anhui Chest Hospital
Phase 2 Unknown
NCT05070598 2021-10-07
Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer
Shengjing Hospital
Phase 2 Unknown
NCT03154983 2020-12-09
The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer
Zhongnan Hospital
Phase 2 Unknown
NCT04571489 2020-10-01
A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer
Lee's Pharmaceutical Limited
Phase 2 Unknown
NCT04216758 2020-06-30
Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer
Fudan University
Phase 2 Unknown
NCT04135781 2020-03-23
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage â…¢ Gastric Cancer
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT04310774 2020-03-19
CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer
Peking Union Medical College Hospital
Phase 1/2 Unknown
NCT04202484 2019-12-17
Tripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction Adenocarcinoma
RenJi Hospital
Phase 2 Unknown
NCT03121313 2019-02-12
Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+
Chang Gung Memorial Hospital
Phase 2 Unknown
NCT03702491 2018-10-11
Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2 Unknown
NCT03475615 2018-03-23
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites
Fudan University
Phase 3 Unknown
NCT03175705 2018-01-18
Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC
Beijing YouAn Hospital
Phase 1 Unknown
NCT03204019 2017-06-29
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor
ChineseAMS
Phase 2 Unknown
NCT03204032 2017-06-29
A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor
ChineseAMS
Phase 2 Unknown
NCT02836977 2017-02-08
Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection
Kaohsiung Medical University Chung-Ho Memorial Hospital
Phase NA Unknown
NCT02943252 2016-10-24
The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT02887365 2016-09-07
A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer
National Taiwan University Hospital
Phase 4 Unknown
NCT02623153 2015-12-07
Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT02280070 2014-10-31
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).
Clinical Research Support Center Kyush
Phase 2 Unknown
NCT00336947 2013-05-15
S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00385970 2012-10-26
A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer
Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
Phase 3 Unknown
NCT00855881 2011-07-26
Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma
Mackay Memorial Hospital
Phase 2 Unknown
NCT01198392 2011-07-25
Trial of S-1 Plus Cisplatin in Gastric Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT00209742 2010-05-26
Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 3 Unknown
NCT00890188 2009-05-07
UFUR
National Cheng-Kung University Hospital
Phase 2 Unknown
NCT00384800 2009-02-09
A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)
Far Eastern Memorial Hospital
Phase 2 Unknown
NCT00497107 2008-07-31
ICOG
Iwate Medical University
Phase 3 Unknown
NCT00625352 2008-02-28
Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma
Ulsan University Hospital
Phase 2 Unknown
NCT00139971 2006-01-06
Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer
West Japan Thoracic Oncology Group
Phase 3 Unknown
NCT00037089 2005-06-24
A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer
Edelman, Martin, M.D.
Phase 2 Unknown